Demand and Trend Analysis of Liquid Dietary Supplements in East Asia (2023 - 2033)
Study on Liquid Dietary Supplements in East Asia by Amino Acids, Botanicals, and Vitamins & Minerals for Men, Women, Kids, and Senior Citizens from 2024 to 2034
Core Findings
FREE CustomizationLiquid Dietary Supplement Sales Outlook for East Asia (2024 to 2034)
Liquid dietary supplement sales in East Asia are estimated at US$ 9.89 billion in 2024, as per the latest Fact.MR study. Regional demand for liquid nutritional supplements is forecasted to accelerate at 9.5% CAGR and reach a market value of US$ 22.64 billion by the end of 2034.
Similar to other regions in the world, an increasing number of people in East Asia are seeking products that can enhance their vitality and health. Busy lifestyles and rapid urbanization in regional countries, including Japan, South Korea, China, etc. are projected to result in increased dependency on on-the-go and convenient food options. Dietary changes in people are also projected to lead to the rising adoption of liquid dietary supplements to obtain the required nutrients.
Culture in East Asia has a tradition of using natural ingredients and remedies owing to their health benefits. Increased preference for conventional medicine is majorly influencing sales of liquid dietary supplements that include conventional ingredients, herbal extracts, or formulations that align with several medicinal practices.
Investments in the formulation as well as packaging of liquid dietary supplements are being made to match changing consumer preferences. Market players are coming up with functional ingredients, targeted formulations, and new flavors to increase their share in this highly competitive landscape.
| Report Attributes | Details |
|---|---|
| Liquid Dietary Supplement Sales in East Asia (2024E) | US$ 9.89 Billion |
| Projected Sales (2034F) | US$ 24.5 Billion |
| Demand Growth (2024 to 2034) | 9.5% CAGR |
| Women Segment Value (2024E) | US$ 5.50 Billion |
| Market Growth in South Korea (2024 to 2034) | 6.2% CAGR |
| Market Share of General Wellbeing Segment (2024E) | 27% |
| Key Companies Profiled | Amway Corporation; Herbalife International; Bayer AG; Abbott Laboratories; GlaxoSmithKline Plc.; Glanbia Plc.; Koninklijke DSM NV; BASF SE; Otsuka Pharmaceutical Co., Ltd.; Taisho Pharmaceutical Co., Ltd.; Ezaki Glico Co., Ltd |
What is Positively Impacting the Sales of Liquid Dietary Supplements in East Asia?
“Rising Consumption of Supplements Due to Increasing Urbanization and Busy Lifestyles”
Fast-paced lifestyles and urbanization in regional countries, including Japan, China, and South Korea are impacting the dietary habits of consumers. This shift is propelling demand for ready-to-eat nutritional food products, including liquid dietary supplements. Urban dwellers generally face issues related to time constraints owing to their several social commitments, demanding work schedules, and long commutes.
It becomes challenging for many individuals to prepare well-balanced meals regularly. Adoption of liquid dietary supplements ensures convenient and quick alternatives to obtain pivotal nutrients without any requirement for extensive meal preparation.
Easy to consume and the portability of liquid dietary supplements make them a suitable option for people constantly on the move. These liquid wellness products can be carried easily whether facing busy workdays, traveling, or commuting to work.
More consumers are adopting these liquid health supplements because of their faster absorption compared to capsules or pills. Individuals seeking quicker nutrient uptake or who have sensitive digestive systems are adopting liquid dietary supplements significantly. Rising number of urban dwellers are giving priority to their health despite their busy schedules. They are becoming conscious of the importance of following a balanced diet and liquid dietary supplements are adopted as an easy and quick way to support health.
Country-wise Insights
What are the Sales Projections for Liquid Dietary Supplements in China?
“Rising Aging Population and Health & Wellness Trends Driving Demand for Dietary Supplements”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 5.76 Billion |
| Growth Rate (2024 to 2034) | 10.6% CAGR |
| Projected Value (2034F) | US$ 15.80 Billion |
China has a significant number of the aging population. With growing age, it generally becomes difficult to swallow pills. Liquid dietary formulations are more appealing and accessible to elderly people who encounter difficulty with conventional forms of dietary supplements.
In recent years, more people in China are emphasizing wellness and health in the country. Therefore, an increase in the demand for liquid dietary supplements is experienced to support well-being. Among other forms, liquid dietary supplements are adopted as an effective and convenient way to improve healthcare.
Why is Japan a Profitable Market for Suppliers of Liquid Dietary Supplements?
“Rising Health Consciousness and Inclination toward Natural Health Approaches”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 3.11 Billion |
| Growth Rate (2024 to 2034) | 8.3% CAGR |
| Projected Value (2034F) | US$ 6.9 Billion |
A high number of Japanese are inclined to a health-conscious lifestyle. More consumers are becoming conscious about their well-being and overall health. Liquid wellness products are perceived as one of the convenient ways to achieve nutritional goals.
An increasing inclination in Japan toward holistic and natural health approaches is forecasted to stimulate demand for liquid dietary supplements. They are generally produced from natural ingredients, including plants or herb extracts, to align with the increasing preference for traditional medicine and natural remedies.
Category-wise Insights
Which Ingredients are Widely Used in Liquid Dietary Supplements in East Asia?
“Increasing Adoption Vitamin-based Supplements to Improve Body Metabolism”
| Attribute | Vitamins & Minerals |
|---|---|
| Segment Value (2024E) | US$ 4.30 Billion |
| Growth Rate (2024 to 2034) | 9.2% CAGR |
| Projected Value (2034F) | US$ 10.4 Billion |
Demand for vitamins & minerals-based liquid dietary supplements is increasing at a significant rate in East Asia because of rising incidences of chronic diseases. Moreover, they are consumed to improve body metabolism to minimize incidences related to lifestyle disorders.
Demand for vitamin-based dietary supplements is forecasted to come from sports athletes and working professionals prominently, as per the study by Fact.MR, a market research and competitive intelligence provider.
Which End User Accounts for High Consumption of Liquid Dietary Supplements?
“Easy Consumption and Tailored Formulations for Geriatric Population”
| Attribute | Senior Citizens |
|---|---|
| Segment Value (2024E) | US$ 1.72 Billion |
| Growth Rate (2024 to 2034) | 8.8% CAGR |
| Projected Value (2034F) | US$ 4 Billion |
Senior citizens face issues in swallowing tablets or pills owing to several age-related issues or health conditions, including dysphasia. Liquid dietary formulations provide an easier-to-swallow alternative. Therefore, it becomes comparatively easier for them to take essential nutrients.
Liquid dietary supplements are formulated at regular intervals to address particular health issues that are common among elderly people, including cognitive function, overall vitality, eye health, heart health, bone density, and joint health. These formulations are designed specifically to match the nutritional requirements of older people in East Asia.
Competition Landscape
Companies offering liquid dietary supplements are investing to attain several goals, including ensuring the management of the supply chain, new development, quality control, etc.
Prominent players operating in the East Asia region include Amway Corporation, Herbalife International, Bayer AG, Abbott Laboratories, GlaxoSmithKline Plc., Glanbia Plc., Koninklijke DSM NV, BASF SE, Otsuka Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., and Ezaki Glico Co., Ltd.
Segmentation of Liquid Dietary Supplement Study in East Asia
-
By Ingredient :
- Amino Acids
- Botanicals
- Vitamins & Minerals
-
By End User :
- Men
- Women
- Kids
- Senior Citizens
-
By Distribution Channel :
- Health & Beauty Stores
- Hypermarkets/Supermarkets
- Online Retail
- Pharmacies & Drug Stores
-
By Application :
- Bone & Joint Health
- General Wellbeing
- Heart Health
- Immune & Digestive Health
- Sports Nutrition
- Weight Loss
-
By Country :
- China
- Japan
- South Korea
Table of Content
- 1. East Asia Industry - Executive Summary
- 2. East Asia Industry Overview
- 3. Industry Risks and Trends Assessment
- 4. Industry Background and Data Points
- 5. East Asia Industry Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 6. East Asia Industry Analysis 2018 to 2023 and Forecast 2024 to 2034, By Ingredient
- 6.1. Amino Acids
- 6.2. Botanicals
- 6.3. Vitamins & Minerals
- 6.4. Others
- 7. East Asia Industry Analysis 2018 to 2023 and Forecast 2024 to 2034, by End User
- 7.1. Men
- 7.2. Women
- 7.3. Kids
- 7.4. Senior Citizens
- 8. East Asia Industry Analysis 2018 to 2023 and Forecast 2024 to 2034, by Application
- 8.1. Bone & Joint Health
- 8.2. General Wellbeing
- 8.3. Heart Health
- 8.4. Immune & Digestive Health
- 8.5. Sports Nutrition
- 8.6. Weight Loss
- 8.7. Other Applications
- 9. East Asia Industry Analysis 2018 to 2023 and Forecast 2024 to 2034, by Distribution Channel
- 9.1. Health & Beauty Stores
- 9.2. Hypermarkets/Supermarkets
- 9.3. Online Retail
- 9.4. Pharmacies & Drug Stores
- 9.5. Others
- 10. East Asia Industry Analysis 2018 to 2023 and Forecast 2024 to 2034, by Country
- 10.1. China
- 10.2. Japan
- 10.3. South Korea
- 11. China Industry Analysis 2018 to 2023 and Forecast 2024 to 2034
- 12. Japan Industry Analysis 2018 to 2023 and Forecast 2024 to 2034
- 13. South Korea Industry Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. Industry Structure Analysis
- 15. Competition Analysis
- 15.1. Amway Corporation
- 15.2. Herbalife International
- 15.3. Bayer AG
- 15.4. Abbott Laboratories
- 15.5. GlaxoSmithKline Plc.
- 15.6. Glanbia Plc.
- 15.7. Koninklijke DSM NV
- 15.8. BASF SE
- 15.9. Otsuka Pharmaceutical Co., Ltd.
- 15.10. Taisho Pharmaceutical Co., Ltd.
- 15.11. Ezaki Glico Co., Ltd.
- 16. Assumptions and Acronyms Used
- 17. Research Methodology
List Of Table
Table 01: East Asia Industry Value (US$ Mn) Analysis, by Ingredient, 2018 to 2023
Table 02: East Asia Industry Value (US$ Mn) Analysis, by Ingredient, 2024 to 2034
Table 03: East Asia Industry Value (US$ Mn) Opportunity Analysis, by Ingredient, 2024 to 2034
Table 04: East Asia Industry Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 05: East Asia Industry Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 06: East Asia Industry Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 07: East Asia Industry Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 08: East Asia Industry Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 09: East Asia Industry Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 10: East Asia Industry Value (US$ Mn) Analysis, by Distribution Channel, 2018 to 2023
Table 11: East Asia Industry Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 12: East Asia Industry Value (US$ Mn) Opportunity Distribution Channel, by Application, 2024 to 2034
Table 13: East Asia Industry Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 14: East Asia Industry Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: East Asia Industry Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: China Industry Value (US$ Mn) Analysis, by Ingredient, 2018 to 2023
Table 17: China Industry Value (US$ Mn) Analysis, by Ingredient, 2024 to 2034
Table 18: China Industry Value (US$ Mn) Opportunity Analysis, by Ingredient, 2024 to 2034
Table 19: China Industry Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 20: China Industry Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 21: China Industry Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 22: China Industry Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 23: China Industry Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 24: China Industry Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 25: China Industry Value (US$ Mn) Analysis, by Distribution Channel, 2018 to 2023
Table 26: China Industry Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 27: China Industry Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 28: Japan Industry Value (US$ Mn) Analysis, by Ingredient, 2018 to 2023
Table 29: Japan Industry Value (US$ Mn) Analysis, by Ingredient, 2024 to 2034
Table 30: Japan Industry Value (US$ Mn) Opportunity Analysis, by Ingredient, 2024 to 2034
Table 31: Japan Industry Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 32: Japan Industry Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 33: Japan Industry Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 34: Japan Industry Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 35: Japan Industry Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 36: Japan Industry Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 37: Japan Industry Value (US$ Mn) Analysis, by Distribution Channel, 2018 to 2023
Table 38: Japan Industry Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 39: Japan Industry Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 40: South Korea Industry Value (US$ Mn) Analysis, by Ingredient, 2018 to 2023
Table 41: South Korea Industry Value (US$ Mn) Analysis, by Ingredient, 2024 to 2034
Table 42: South Korea Industry Value (US$ Mn) Opportunity Analysis, by Ingredient, 2024 to 2034
Table 43: South Korea Industry Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 44: South Korea Industry Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 45: South Korea Industry Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 46: South Korea Industry Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 47: South Korea Industry Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 48: South Korea Industry Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 49: South Korea Industry Value (US$ Mn) Analysis, by Distribution Channel, 2018 to 2023
Table 50: South Korea Industry Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 51: South Korea Industry Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
List Of Figures
Figure 01: East Asia Industry Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 02: East Asia Industry Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: East Asia Industry Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 04: East Asia Industry Incremental $ Opportunity, 2024 to 2034
Figure 05: East Asia Industry Share and BPS Analysis by Ingredient, 2024 & 2034
Figure 06: East Asia Industry Y-o-Y Growth Projections by Ingredient, 2024 to 2034
Figure 07: East Asia Industry Attractiveness Analysis by Ingredient, 2024 to 2034
Figure 08: East Asia Industry Share and BPS Analysis by End User, 2024 & 2034
Figure 09: East Asia Industry Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 10: East Asia Industry Attractiveness Analysis by End User, 2024 to 2034
Figure 11: East Asia Industry Share and BPS Analysis by Application, 2024 & 2034
Figure 12: East Asia Industry Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 13: East Asia Industry Attractiveness Analysis by Application, 2024 to 2034
Figure 14: East Asia Industry Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 15: East Asia Industry Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 16: East Asia Industry Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 17: East Asia Industry Share and BPS Analysis by Country, 2024 & 2034
Figure 18: East Asia Industry Y-o-Y Growth Projections by Country, 2024 to 2034
Figure 19: East Asia Industry Attractiveness Analysis by Country, 2024 to 2034
Figure 20: China Industry Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 21: China Industry Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 22: China Industry Value Y-o-Y Growth and Forecast, 2034
Figure 23: China Industry Incremental $ Opportunity, 2024 to 2034
Figure 24: China Industry Share and BPS Analysis by Ingredient, 2024 & 2034
Figure 25: China Industry Y-o-Y Growth Projections by Ingredient, 2024 to 2034
Figure 26: China Industry Attractiveness Analysis by Ingredient, 2024 to 2034
Figure 27: China Industry Share and BPS Analysis by End User, 2024 & 2034
Figure 28: China Industry Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 29: China Industry Attractiveness Analysis by End User, 2024 to 2034
Figure 30: China Industry Share and BPS Analysis by Application, 2024 & 2034
Figure 31: China Industry Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 32: China Industry Attractiveness Analysis by Application, 2024 to 2034
Figure 33: China Industry Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 34: China Industry Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 35: China Industry Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 36: Japan Industry Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 37: Japan Industry Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 38: Japan Industry Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 39: Japan Industry Incremental $ Opportunity, 2024 to 2034
Figure 40: Japan Industry Share and BPS Analysis by Ingredient, 2024 & 2034
Figure 41: Japan Industry Y-o-Y Growth Projections by Ingredient, 2024 to 2034
Figure 42: Japan Industry Attractiveness Analysis by Ingredient, 2024 to 2034
Figure 43: Japan Industry Share and BPS Analysis by End User, 2024 & 2034
Figure 44: Japan Industry Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 45: Japan Industry Attractiveness Analysis by End User, 2024 to 2034
Figure 46: Japan Industry Share and BPS Analysis by Application, 2024 & 2034
Figure 47: Japan Industry Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 48: Japan Industry Attractiveness Analysis by Application, 2024 to 2034
Figure 49: Japan Industry Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 50: Japan Industry Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 51: Japan Industry Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 52: South Korea Industry Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 53: South Korea Industry Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 54: South Korea Industry Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 55: South Korea Industry Share and BPS Analysis by Ingredient, 2024 & 2034
Figure 56: South Korea Industry Y-o-Y Growth Projections by Ingredient, 2024 to 2034
Figure 57: South Korea Industry Attractiveness Analysis by Ingredient, 2024 to 2034
Figure 58: South Korea Industry Share and BPS Analysis by End User, 2024 & 2034
Figure 59: South Korea Industry Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 60: South Korea Industry Attractiveness Analysis by End User, 2024 to 2034
Figure 61: South Korea Industry Share and BPS Analysis by Application, 2024 & 2034
Figure 62: South Korea Industry Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 63: South Korea Industry Attractiveness Analysis by Application, 2024 to 2034
Figure 64: South Korea Industry Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 65: South Korea Industry Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 66: South Korea Industry Attractiveness Analysis by Distribution Channel, 2024 to 2034
- FAQs -
What are the sales projections for liquid dietary supplements in East Asia?
Sales of liquid dietary supplements in East Asia are estimated at US$ 9.89 billion in 2024.
What is the anticipated value of the East Asia market for 2034?
The market in East Asia is predicted to reach US$ 24.5 billion by the end of 2034.
What is the projected CAGR for liquid dietary supplement demand?
Regional demand for liquid dietary supplements is forecasted to accelerate at 9.5% CAGR from 2024 to 2034.
What is the estimated value of the market in South Korea?
Sales of liquid dietary supplements in South Korea are pegged at US$ 1.02 billion in 2024.
At what rate is the demand for liquid dietary supplements anticipated to increase from women?
Sales of liquid dietary supplements for women are forecasted to rise at 7.4% CAGR through 2034.
What is the projected value of liquid dietary supplement sales in Japan by 2034-end?
Demand for liquid dietary supplements in Japan is set to reach a valuation of US$ 6.90 billion by 2034.
What is the demand value of liquid dietary supplements in China in 2024?
Demand for liquid dietary supplements in China is estimated at US$ 5.76 billion in 2024.
Related Reports
Demand and Trend Analysis of Liquid Dietary Supplements in East Asia